MG
MOR

Michael Gelband’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Michael Gelband’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,100
Closed -$129K – 2203
2024
Q2 		$129K Sell
7,100
-50,000
-88% -$909K ﹤0.01% 1416
2024
Q1 		$1.04M Buy
+57,100
New +$844K 0.01% 935

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Michael Gelband's MOR Position: Q3 2024 in Review

Michael Gelband sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 465 shares — an estimated $8K sold.

Michael Gelband first reported a position in MOR in Q4 2021 and held it in 5 quarters. The position peaked at $1.72M in Q3 2023. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • Michael Gelband reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Michael Gelband sold 465 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $8K.
  • Michael Gelband first reported a position in MorphoSys AG American Depositary Shares in Q4 2021 and held it in 5 quarters.
  • Michael Gelband's MorphoSys AG American Depositary Shares position peaked at $1.72M in Q3 2023.
  • 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.